Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbit

BACKGROUND AND PURPOSE: Most patients at elevated cardiovascular risk receive long-term aspirin (ASA) anti-platelet treatment. The present study specifically addresses the pharmacological interactions between selective COX-2 inhibitors and ASA and the possible consequences for the thrombotic risk du...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kaber, G, Kaiser, B, Baumgärtel-Allekotte, D, Rauch, BH, Noßmann, S, Heim, KH, Weber, AA, Nagy, N, Fischer, JW, Schrör, K
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Publishing Ltd 2011
Konular:
Themed Section: Cardiovascular Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3188910/
https://ncbi.nlm.nih.gov/pubmed/21457221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2011.01392.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller